The promoter mutation of PLEKHS1 was found in iodine-incurable thyroid cancer, and it can be combined with the TERT promoter, BRAF, RAS, and TP53 as classification tools to classify patients with differentiated thyroid cancer who have distal metastases [65]. This evidence concerns the gene BRAF and thyroid gland carcinoma.